Beginner's Mind

For more than 10 years the blockchain technology has shaped our economy. The background technology is mostly invisible for average users like me.

On the front end, cryptocurrency has hit the news. I remember well the highs of Bitcoin in 2017. And recently, Bitcoin is rising again.

But, and this is something I want to learn, what applications do exist that can improve the life science industries? Is there something else in the background that will help us solve the problems we have in drug development, medical devices, diagnostics, and digital health?

These and many more questions will be answered by the experts Paul Kohlhaas and Astrid Woollard.

Join us on this Life Science specific Blockchain update.

Link to the Video of the Recording:
YouTube

Do you prefer reading?
Here is your Transcript ready for purchase in the LSG2G Etsy Shop.

Speaker:
Astrid Woollard
Christian Soschner
Paul Kohlhaas

Organizations:
CS Life Science Invest
Molecule.to
Scytale Ventures

Be part of our Network:
Subscribe here:  https://mailchi.mp/e2467061ef75/lsg2g

Support the show (https://www.lifescienceget2gether.com/registration-membersclub/)

The LSG2G Partners
Experts in Life Science



This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit lsg2g.substack.com/subscribe

A new year brings new tax rules.

Astrid Woollard and Christian Soschner asked the Tax Experts of KPMG Austria to give an update on the newest regulations in Austria.

We also had a chance to talk about tax advisors and auditors' roles in the start-up economy.

Listen to this episode to learn what's new and when to consult advisors.

If you have questions after listening to the episode, reach out to Michael and Oliver.

For the videophile:
The Video to the Podcast

Resources mentioned in the podcast:
Research Premium and its role in Fundraising
Government and institution measures in response to COVID-19
COVID-19 Tax Info (in German)
Folge #099: Tax Hacks & Fun Stuff aus der Start-up-Beratungspraxis (in German)

Speaker:
Astrid Woollard
Christian Soschner
Michael Klewan
Oliver Mavher

Organizations:
CS Life Science Invest
KPMG Austria
Scytale Ventures

Show Notes:
00:11:27 Home Office and Taxation
00:14:34 Funding and SMEs
00:17:44  Solvency and Zombie Companies
00:20:54 Cryptocurrency
00:24:41 The Role of Tax Consultants and Auditors in Start-Up Companies
00:31:58 AI in Bookkeeping
00:36:00 Secrets of Auditing in the Start-Up World
00:44:12 Wirecard and Auditing
00:54:40 Tax Deadlines and Tax Breaks in 2021
01:04:14 Research Premium and SAAS
01:26:17 Critical Deadlines in 2021
01:29:00 Tax Loss Carry Backwards
01:34:00 New VC Fund for Start-Ups in Austria
01:38:00 Invitation to Reach Out to Michael and Oliver.



Be part of our Network:
Subscribe here:  https://mailchi.mp/e2467061ef75/lsg2g

Support the show (https://www.lifescienceget2gether.com/registration-membersclub/)

The LSG2G Partners
Experts in Life Science



This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit lsg2g.substack.com/subscribe

What was hot and what not - in Blockchain and Life Science and other Tech Areas the speakers love.

Listen about what was going on in the world in 2020 - besides SARS CoV 2.

Speaker:
Albert Missbichler (https://www.linkedin.com/in/albert-missbichler-3a362931/)
Astrid Woollard (https://www.linkedin.com/in/astridwoollard/)
Christian Soschner (https://www.linkedin.com/in/christiansoschner/)
Elisabeth Pfneisl (https://www.linkedin.com/in/elisabeth-pfneisl-81095163/)
Gregory Mannix (https://www.linkedin.com/in/greg-mannix/)
Irina Korschineck (https://www.linkedin.com/in/irina-korschineck-35a40289/)
Jama Nateqi (https://www.linkedin.com/in/jama-nateqi/)
Julia Resch (https://www.linkedin.com/in/julia-resch/)
Kimberly Cornfield (https://www.linkedin.com/in/kimberly-cornfield-55383136/)
Klara Brandstätter (https://www.linkedin.com/in/klara-brandst%C3%A4tter-b6029491/)
Matthias Tarasiewicz (https://www.linkedin.com/in/parasew/)
Michael Browne (https://www.linkedin.com/in/michael-browne-frsa-5a616138/)
Thomas Schirrmann (https://www.linkedin.com/in/thomas-schirrmann-45a64183/)

Organizations:
Corat Therapeutics (https://www.linkedin.com/company/corat-therapeutics/)
CS Life Science Invest (https://lnkd.in/eyhWK7H)
Crowdhelix (https://www.linkedin.com/company/crowdhelix/)
Falcon Digital Investment (https://www.linkedin.com/company/falcon-digital-investments/about/)
Fianostics (https://www.fianostics.at/en/home/)
IECT Hermann Hauser (https://www.linkedin.com/company/iect-hermann-hauser)
Ingenetix (https://www.ingenetix.com/en/home/)
Life Science Nation (https://www.linkedin.com/company/life-science-nation/)
RIAT - Research Institute for Future Cryptoeconomics  (https://riat.at/)
Symptoma (https://www.linkedin.com/company/symptoma/)
UCL (https://www.linkedin.com/school/university-college-london/)
Vienna Stock Exchange (https://www.linkedin.com/company/wiener-borse-ag/)
Yumab (https://www.linkedin.com/company/yumab-gmbh/)

Support the show (https://www.lifescienceget2gether.com/registration-membersclub/)

The LSG2G Partners
Experts in Life Science



This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit lsg2g.substack.com/subscribe

At the beginning of the new millennium, the next technological quantum leap began to emerge, known as the fourth industrial revolution – or Industry 4.0 for short. New technologies permit the development of new business models. In general, a business model describes a company’s business processes to achieve a defined business objective within the context of its social environment. The term sums up visions, ideas, defining features, and design models.

In the context of digitization, intellectual property (IP) is becoming an increasingly important element in a company’s strategy to remain competitive by establishing defensible positions. This importance necessitates systematic and value-driven management of IP. In light of the shift from a production-oriented towards a software-driven economy, finding valuable ideas has become a challenging task. The formation of digitalized eco-systems allows new market entrants to compete with established companies easily. Therefore, understanding how intellectual property rights can protect aspects of such digital business models is desirable.

For the videophile:
The Video to the Podcast

Speaker:
Prof. Alexander Wurzer (https://www.linkedin.com/in/profalexanderwurzer/)
Astrid Woollard (https://www.linkedin.com/in/astridwoollard/)
Christian Soschner (https://www.linkedin.com/in/christiansoschner/)

Organizations:
CS Life Science Invest (https://lnkd.in/eyhWK7H)
Falcon Digital Investment (https://www.linkedin.com/company/falcon-digital-investments/about/)
IP Business Academy (https://www.linkedin.com/company/ipbusinessacademy/)

Be part of our Network:
Subscribe here:  https://mailchi.mp/e2467061ef75/lsg2g

Support the show (https://www.lifescienceget2gether.com/registration-membersclub/)

The LSG2G Partners
Experts in Life Science



This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit lsg2g.substack.com/subscribe

Let's sit down for a conversation about my favorite topic: Fundraising in the Life Science Industry.

How is it to raise significant financing rounds during a pandemic when the research focus is not related to SARS-CoV-2?

It is my pleasure to welcome Dr. Daniela Marino, CEO and Co-founder of Cutiss AG.

Speaker:
Christian Soschner (https://www.linkedin.com/in/christiansoschner/)
Daniela Marino  (https://www.linkedin.com/in/daniela-marino-3bb35a26/)

Organizations:
CS Life Science Invest (https://lnkd.in/eyhWK7H)
Cutiss AG (https://www.linkedin.com/company/cutiss-ag/)

Be part of our Network:
Subscribe here:  https://mailchi.mp/e2467061ef75/lsg2g

Support the show (https://www.lifescienceget2gether.com/registration-membersclub/)

This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit lsg2g.substack.com/subscribe

In the last episodes, I have talked with investors and decision-makers of the pharmaceutical industry about the importance of having a vision and passion for the life science company.

I want to explore this topic further and ask the life science entrepreneur Christof Goetz to chat with me about finding your vision and passion for your company.

Christof is a Serial Entrepreneur with more than 20 years of experience managing complex business, software, and hardware development projects. 

MyMind is a life science company based in Vienna. MyMinds vision is to help people with neurological impairments to live towards their full brain potential with affordable and easy to use brain training and assessment technology. MyMind currently focuses on Autism Spectrum Disorders (ASD), whether comorbid with Attention Deficit Hyperactivity Disorder (ADHD), Intellectual Disability (low IQ), Epilepsy, and Anxiety. Subsequently, MyMind will extend to other neurological issues such as dementia or stroke recovery.

Speaker:
Christof Goetz (https://www.linkedin.com/in/christofgoetz/)
Christian Soschner (https://www.linkedin.com/in/christiansoschner/)

Organizations:
CS Life Science Invest (https://lnkd.in/eyhWK7H)
My Mind GmbH (https://www.linkedin.com/company/mymindvienna/)

Be part of our Network:
Subscribe here:  https://mailchi.mp/e2467061ef75/lsg2g

Support the show (https://www.lifescienceget2gether.com/registration-membersclub/)

The LSG2G Partners
Experts in Life Science



This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit lsg2g.substack.com/subscribe

In this episode, I had the pleasure of talking with two Diagnostics Experts.

Irina Korschinek, CEO of Ingenetix and Albert Missbichler, Business Angel specialized in Diagnostics.

Do you want to know answers to all or one of the following questions?

• What is a PCR test?
• Why is it the gold standard for measuring SARS-Cov2 Infections?
• What does a positive or negative test result say?
• Why do false positives and false negatives exist. Shouldn`t the test have 100% accuracy?
• Why do no yes or no answers exist to a viral infection?
• What makes diagnostics so complex?

Speaker:
Albert Missbichler (https://www.linkedin.com/in/albert-missbichler-3a362931/
Christian Soschner (https://www.linkedin.com/in/christiansoschner/)
Irina Korschinek (https://www.linkedin.com/in/irina-korschineck-35a40289/)

Organizations:
CS Life Science Invest (https://lnkd.in/eyhWK7H)
Ingenetix (https://www.ingenetix.com/en/home/)
Fianostics (https://www.fianostics.at/en/home/)

Be part of our Network:
Subscribe here:  https://mailchi.mp/e2467061ef75/lsg2g

Support the show (https://www.lifescienceget2gether.com/registration-membersclub/)

The LSG2G Partners
Experts in Life Science



This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit lsg2g.substack.com/subscribe

Did you know that the successful pipeline of one of the most important pharmaceutical companies in the United States started in Europe, and scientists from Prague played a key role? Did you know that profound expertise in turning deep tech life science into a business, scale it, and go public in the US can be found in Prague since the late 80s of the previous century?

If you want to know which US pharmaceutical companies pipeline started in Prague, then listen to this Episode Number 25. I am delighted to host an exceptional guest from one of the most beautiful cities in Europe. I will talk with Karel Kubias, from  i&i in Prague.

Karel studied organic chemistry and photochemistry at TH Merseburg, Germany, and holds an MBA in Healthcare Management (Auburn University program).

He gained his broad professional knowledge and skills during his 24 years in various management positions at multinational chemical and pharmaceutical company Merck KGaA. Between 2006 – 2015, Karel worked in executive positions – first as Managing Director of Merck spol. s r.o.. Prague and then as Regional sales director for the region EEMEA (Eastern Europe, Middle East & Africa) of Merck Millipore division, where he acquired further experience on the international level. He now supports i&i Prague as Director for Partnerships and Strategic Alliances.

i&i Prague is accelerating the proof-of-concept stage of projects in the fields of Medtech, Diagnostics, and Drug discovery. The company focuses on projects in the discovery, pre-seed, or seed phase, projects with excellent innovative potential, which will benefit from the project-launching experience and networking skills developed by IOCB Tech over the last decade. Furthermore, the financial support provided by i&i Prague should significantly increase the appeal and value of a project for further licensees and/ or investors.

Speaker:
Christian Soschner (https://www.linkedin.com/in/christiansoschner/)
Karel Kubias (https://www.linkedin.com/in/karelkubias/)

Organizations:
CS Life Science Invest (https://lnkd.in/eyhWK7H)
i&i Prague (https://www.linkedin.com/company/iniprague/)
IOCB Tech (https://www.linkedin.com/company/iocb-tto-s-r-o-/)
IOCB (https://www.linkedin.com/company/iocb-prague/)

Be part of our Network:
Subscribe here:  https://mailchi.mp/e2467061ef75/lsg2g

Support the show (https://www.lifescienceget2gether.com/registration-membersclub/)

The LSG2G Partners
Experts in Life Science



This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit lsg2g.substack.com/subscribe

Listen to my inspiring conversation with Vassilis Ragoussis about initiatives that support young scientists to become Entrepreneurs.

We dived deep into the entrepreneurial Life Science Eco-System in Oxford, Europe, and the United States.

If you want to know what the Eco-System in Oxford is doing for young scientist entrepreneurs, this podcast is for you.

Learn more about Oxford University Biotech Society and Oxford Foundry.

Vassilis is an avid networker and a Ph.D. student at the University of Oxford studying Clinical Medicine. His research requires to analyze large amounts of next-generation sequencing data using bioinformatics and computational analysis. In addition, he critically and objectively assesses his findings, validating any discoveries with functional experiments. During his time at Boston University and Oxford University, he competed at the highest level of rowing, dedicating 30+ hours a week to training and competing, gaining a profound understanding and tremendous respect for teamwork, time management, and team leadership. He has a strong interest in venture capital, life science consulting, and medical device innovations.

Speaker:
Christian Soschner
Vassilis Ragoussis

Organizations:
CS Life Science Invest (https://lnkd.in/eyhWK7H)
Oxford Foundry
Oxford University Biotech Society
University of Oxford

Be part of our Network:
Subscribe here:  https://mailchi.mp/e2467061ef75/lsg2g

Support the show (https://www.lifescienceget2gether.com/registration-membersclub/)

The LSG2G Partners
Experts in Life Science



This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit lsg2g.substack.com/subscribe

Listen to my conversation with Nicolaj Højer Nielsen about the life of an early-stage investors in Europe.

Nicolaj Højer Nielsen is a serial entrepreneur and business angel who has been building startups since 1999. He focuses on high potential startups and has co-founded and invested in thirteen companies, primarily within IT. He has experience securing funding from all possible sources – friends and family, business angels, VC funds, and public funds. His expertise is based on reviewing thousands of different investment opportunities, and he knows the fundraising process from both sides of the table.

His latest venture is Copenhagen United, an investment fund focusing on providing capital and mentoring for early-stage software companies.

Let`s chat with him about his view on the early-stage investment eco-system in Europe.

Speaker:
Christian Soschner
Nicolaj Højer Nielsen

Companies:
CS Life Science Invest (https://lnkd.in/eyhWK7H)
InProTher

Be part of our Network:
Subscribe here:  https://mailchi.mp/e2467061ef75/lsg2g

Support the show (https://www.lifescienceget2gether.com/registration-membersclub/)

The LSG2G Partners
Experts in Life Science



This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit lsg2g.substack.com/subscribe